PofoliaShared via Pofolia

Journal of Experimental & Clinical Cancer Research· 2019Q1

Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology

Neel I. Nissen, M.A. Karsdal, Nicholas Willumsen

Short summary

Stromal collagens, particularly fibrillar types I, III, and V, are remodeled by cancer-associated fibroblasts (CAFs) to alter tumor microenvironment architecture, driving tumorigenesis and impacting treatment response.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Stromal collagens, particularly fibrillar types I, III, V, XI, XXIV, and XXVII, are major components of the extracellular matrix supporting the tumor stroma.
  • Cancer-associated fibroblasts (CAFs) are the primary cells responsible for remodeling these stromal collagens.
  • Altered stromal collagen composition and CAFs' activity significantly impact tumor microenvironment architecture and tissue microarchitecture.
  • This remodeling drives tumorigenesis and affects patient response to cancer treatments.
  • Specific collagen-derived biomarkers may offer non-invasive tools to evaluate stromal reactivity and predict treatment outcomes.

AI-generated from the title and abstract; the full text is not read.

Abstract

The extracellular matrix (ECM) plays an important role in cancer progression. It can be divided into the basement membrane (BM) that supports epithelial/endothelial cell behavior and the interstitial matrix (IM) that supports the underlying stromal compartment. The major components of the ECM are the collagens. While breaching of the BM and turnover of e.g. type IV collagen, is a well described part of tumorigenesis, less is known regarding the impact on tumorigenesis from the collagens residing in the stroma. Here we give an introduction and overview to the link between tumorigenesis and stromal collagens, with focus on the fibrillar collagens type I, II, III, V, XI, XXIV and XXVII as well as type VI collagen. Moreover, we discuss the impact of the cells responsible for this altered stromal collagen remodeling, the cancer associated fibroblasts (CAFs), and how these cells are key players in orchestrating the tumor microenvironment composition and tissue microarchitecture, hence also driving tumorigenesis and affecting response to treatment. Lastly, we discuss how specific collagen-derived biomarkers reflecting the turnover of stromal collagens and CAF activity may be used as tools to non-invasively interrogate stromal reactivity in the tumor microenvironment and predict response to treatment.

The authors' abstract, as published at the source. Journal of Experimental & Clinical Cancer Research, 2019 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Immunology and Allergy

Immunology and AllergyMedicine